Save up -80% on Elbasvir
|Note: this is a drug discount program, not an insurance plan.|
|RX BIN: 015558||RX PCN: HT||Group ID: DDN6600||Card Holder ID: DDN6600|
|Pharmacists and Patients support.|
2019 Price of Zepatier
|$7,215.60||28 tablets/50 mg|
|price without discount in nearest pharmacy. Price may vary.|
We offer free Elbasvir coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your manufacturer copay card in most local pharmacies to get a discount on Elbasvir every time. What are you waiting for? Claim your prescription drug card now!
Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time
Elbasvir volume of distribution
Elbasvir has an estimated apparent volume of distribution of 680 liters. It is thought to distribute into most tissues including the liver. Elbasvir is more than 99.9% bound to plasma proteins.
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Elbasvir
Elbasvir is an inhibitor of the Hepatitis C Virus (HCV) Non-Structural protein 5A (NS5A). Although NS5A has no known enzymatic function, it has been shown to have multiple functions at various stages of the life cycle, including viral replication, virion assembly, and use within multi-protein binding complexes. Combining elbasvir with other drugs that target other points of the viral life cycle and with non-overlapping resistance profiles results in increased potency and an improved barrier to resistance. Elbasvir is currently approved for use in combination with grazoprevir (as the combination product Zapatier) for the treatment of chronic hepatitis C genotypes 1 and 4.
Elbasvir mechanism of action
Elbasvir is an inhibitor of the Hepatitis C Virus (HCV) Non-Structural protein 5A (NS5A), which is essential for viral RNA replication and virion assembly. By combining two direct-acting antiviral agents with distinct mechanisms of action and non-overlapping resistance profiles (elbasvir and grazoprevir) into the fixed dose combination product Zapatier, this medication targets HCV at multiple steps in the viral lifecycle with improved resistance rates.
Dosage forms of Elbasvir
Merck Canada Inc
Indication of Elbasvir
Elbasvir, when used in combination with grazoprevir as the combination product Zepatier, is indicated for use with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 or 4 infection in adults.
Toxicity of Elbasvir
The most commonly reported adverse reactions during clinical trials were fatigue, headache, anemia, and nausea.
RX24 Drugs Disclaimer: consult your healthcare provider before buying a Elbasvir on prescription or using an RX manufacturer savings coupon. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.